Financials Mednow Inc.

Equities

MDNWF

CA58503L2021

Drug Retailers

Market Closed - OTC Markets 14:30:27 2024-04-01 EDT 5-day change 1st Jan Change
0.000001 USD -100.00% Intraday chart for Mednow Inc. -.--% -100.00%

Valuation

Fiscal Period: July 2021 2022
Capitalization 1 28.74 13.4
Enterprise Value (EV) 1 0.3733 15.43
P/E ratio -2.73 x -0.45 x
Yield - -
Capitalization / Revenue 69,421,639 x 805,402 x
EV / Revenue 901,610 x 927,463 x
EV / EBITDA -41,635 x -739,362 x
EV / FCF -78,066 x -1,729,516 x
FCF Yield -0% -0%
Price to Book 0.88 x 2.2 x
Nbr of stocks (in thousands) 21,663 21,568
Reference price 2 1.327 0.6213
Announcement Date 21-10-21 22-11-29
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2018 2019 2020 2021 2022
Net sales - - - 0.414 16.64
EBITDA - - - -8.965 -20.87
EBIT 1 -0.0135 -0.0116 -0.4695 -8.999 -21.45
Operating Margin - - - -2,173.57% -128.91%
Earnings before Tax (EBT) 1 -0.0135 -0.0116 -0.4695 -8.954 -30.07
Net income 1 -0.0135 -0.0116 -0.4695 -8.954 -29.56
Net margin - - - -2,162.76% -177.63%
EPS - -0.001891 -0.0554 -0.4865 -1.370
Free Cash Flow - -0.1228 -0.356 -4.781 -8.923
FCF margin - - - -1,154.94% -53.63%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 21-01-28 21-01-28 21-01-28 21-10-21 22-11-29
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: July 2018 2019 2020 2021 2022
Net Debt 1 0.01 0.13 - - 2.03
Net Cash position 1 - - 5.21 28.4 -
Leverage (Debt/EBITDA) - - - - -0.0973 x
Free Cash Flow - -0.12 -0.36 -4.78 -8.92
ROE (net income / shareholders' equity) - 93.1% -17.5% -47.3% -154%
ROA (Net income/ Total Assets) - -12.3% -10.4% -28.3% -51.3%
Assets 1 - 0.0946 4.527 31.61 57.66
Book Value Per Share 2 -0 -0 0.3300 1.510 0.2800
Cash Flow per Share 2 0 0 0.3300 1.330 0.2300
Capex - - - 0.65 1.59
Capex / Sales - - - 158.13% 9.58%
Announcement Date 21-01-28 21-01-28 21-01-28 21-10-21 22-11-29
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. MDNWF Stock
  4. Financials Mednow Inc.